HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naifa Lamki Busaidy Selected Research

CVAD protocol

12/2014Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naifa Lamki Busaidy Research Topics

Disease

3Thyroid Neoplasms (Thyroid Cancer)
12/2018 - 01/2012
2Anaplastic Thyroid Carcinoma
12/2018 - 09/2015
1Carcinoma (Carcinomatosis)
09/2015
1Hyperglycemia
12/2014
1Leukemia
12/2014
1Neoplasms (Cancer)
12/2014
1Neoplasm Metastasis (Metastasis)
01/2012

Drug/Important Bio-Agent (IBA)

2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2015 - 12/2014
1Docetaxel (Taxotere)FDA Link
09/2015
1Cisplatin (Platino)FDA LinkGeneric
09/2015
1SteroidsIBA
12/2014
1Insulin (Novolin)FDA Link
12/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2014
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2014
1Glucose (Dextrose)FDA LinkGeneric
12/2014
1Vincristine (Oncovin)FDA LinkGeneric
12/2014
1IodineIBA
01/2012

Therapy/Procedure

4Therapeutics
12/2018 - 01/2012
2Drug Therapy (Chemotherapy)
12/2014 - 01/2012
1CVAD protocol
12/2014